Compare Japfa Comfeed Indonesia Tbk. (JPFA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Japfa Comfeed Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Japfa Comfeed Indonesia Tbk. trades at Rp2,250 (market cap 27.21T, 21.43M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Japfa Comfeed Indonesia Tbk. is far larger — about 260.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| JPFA | SCPI | |
|---|---|---|
Market Cap | 27.21T | 104.4B |
Volume | 21.43M | — |
Lot | 214.28K | — |
Turnover | 48.33B | — |
Average Price | 2,255.47 | — |
Value | 48.33B | — |
Indicative Equilibrium Price | 2,250 | — |
Indicative Equilibrium Volume | 16.2K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Japfa Comfeed Indonesia Tbk.
PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Read more on JPFA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
